Artenimol is an artemisinin derivative. Artenimol is an artemisinin derivative and antimalarial agent used to treat uncomplicated *Plasmodium falciparum* infections. It was first authorized for market by the European Medicines Agency in October 2011 in combination with [DB13941] as the product Eurartesim. Artemisinin combination therapy is highly effective against malaria and stongly recommended by the World Health Organization. It is grouped under the following drug class(es): Terpenes. Its therapeutic use is listed as anti-infectives, antimalarials and antiparasitics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Alaxin, Dihydroartemisinine (DHA), Cotexin and Salaxin. Its PubChem CID is 3000518.
Artenimol
| CAS No | 71939-50-9 |
|---|---|
| Molecular Formula | C15H24O5 |
| Molecular Weight | 284.35 g/mol |
| Synonyms | (1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Artenimol is an artemisinin derivative. Artenimol is an artemisinin derivative and antimalarial agent used to treat uncomplicated *Plasmodium falciparum* infections.
The listed CAS number is 71939-50-9.
The listed molecular formula is C15H24O5.
The listed molecular weight is 284.35 g/mol.
(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol.
The source lists Alaxin, Dihydroartemisinine (DHA), Cotexin and Salaxin.